Advanced Accelerator Applications S.A Total Assets 2015-2017 | AAAP

Advanced Accelerator Applications S.A total assets from 2015 to 2017. Total assets can be defined as the sum of all assets on a company's balance sheet.
Advanced Accelerator Applications S.A Annual Total Assets
(Millions of US $)
2016 $463
2015 $304
2014 $248
Advanced Accelerator Applications S.A Quarterly Total Assets
(Millions of US $)
2017-09-30 $460
2017-06-30 $435
2017-03-31 $439
2016-12-31 $463
2016-09-30 $300
2016-06-30 $309
2016-03-31 $308
2015-09-30 $232
2014-12-31 $248
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.000B $0.000B
Advanced Accelerator Applications S.A. is a radiopharmaceutical company. The company, develops, produces and commercializes molecular nuclear medicine diagnostic and therapeutic products. Its products in clinical development include Lutathera, Somakit and Annexin V-128. The company's commercial products include Gluscan /Gluscan 500/Barnascan(R), IASOflu(R), IASOdopa(R), IASOcholine(R), MIBITEC/Adamibi and Leukokit(R). It operates primarily in France, Italy, the United Kingdom, Spain, Portugal, Israel, Switzerland, Germany and Canada. Advanced Accelerator Applications S.A. is headquartered in Saint Genis Pouilly, France.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $65.827B 37.36
Takeda Pharmaceutical (TAK) Japan $55.678B 9.76
Astellas Pharma (ALPMY) Japan $30.701B 15.56
Eisai (ESALY) Japan $23.773B 20.61
UCB SA (UCBJF) Belgium $23.292B 0.00
Merck (MKGAF) Germany $15.761B 20.67
Grifols, S.A (GRFS) Spain $13.098B 16.28
Neurocrine Biosciences (NBIX) United States $11.855B 54.79
Catalent (CTLT) United States $11.390B 44.03
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $9.945B 0.00
Ono Pharmaceutical (OPHLF) Japan $9.254B 0.00
Ionis Pharmaceuticals (IONS) United States $8.467B 45.02
IPSEN SA ADR (IPSEY) France $7.290B 0.00
Orion OYJ (ORINY) Finland $6.978B 31.27
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.664B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.155B 9.85
United Therapeutics (UTHR) United States $5.239B 9.93
STADA ARZNEIMI (STDAF) Germany $4.916B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $4.450B 485.78
Nektar Therapeutics (NKTR) United States $4.268B 0.00
Evotec AG (EVTCY) Germany $4.181B 112.67
FibroGen (FGEN) United States $3.843B 0.00
Hypermarcas (HYPMY) Brazil $3.838B 11.67
ChemoCentryx (CCXI) United States $3.578B 0.00
PTC Therapeutics (PTCT) United States $3.540B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.609B 10.72
Pacira BioSciences (PCRX) United States $2.285B 46.78
Cronos Group (CRON) Canada $2.250B 64.50
Sage Therapeutics (SAGE) United States $2.178B 0.00
Corcept Therapeutics (CORT) United States $1.916B 19.00
Xencor (XNCR) United States $1.867B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.743B 0.00
Akebia Therapeutics (AKBA) United States $1.702B 0.00
Indivior (INVVY) United States $1.679B 20.84
USANA Health Sciences (USNA) United States $1.672B 17.15
Ironwood Pharmaceuticals (IRWD) United States $1.637B 12.52
Zogenix (ZGNX) United States $1.609B 0.00
Karyopharm Therapeutics (KPTI) United States $1.431B 0.00
Esperion Therapeutics (ESPR) United States $1.404B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.401B 15.10
Heron Therapeutics (HRTX) United States $1.357B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.258B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.250B 0.00
Translate Bio (TBIO) United States $1.095B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.010B 45.09
Tilray (TLRY) Canada $0.980B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.873B 0.00
ImmunoGen (IMGN) United States $0.853B 0.00
Endo (ENDP) Ireland $0.830B 1.29
Radius Health (RDUS) United States $0.657B 0.00
Aerie Pharmaceuticals (AERI) United States $0.648B 0.00
Trillium Therapeutics (TRIL) Canada $0.635B 0.00
Molecular Templates (MTEM) United States $0.635B 0.00
Ardelyx (ARDX) United States $0.629B 0.00
Collegium Pharmaceutical (COLL) United States $0.602B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.573B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.568B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.507B 12.25
Flexion Therapeutics (FLXN) United States $0.505B 0.00
VAXART, INC (VXRT) United States $0.478B 0.00
Innate Pharma SA (IPHYF) France $0.476B 0.00
Siga Technologies (SIGA) United States $0.475B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.458B 17.85
DURECT (DRRX) United States $0.418B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.411B 0.00
Harpoon Therapeutics (HARP) United States $0.411B 0.00
Ocular Therapeutix (OCUL) United States $0.403B 0.00
TherapeuticsMD (TXMD) United States $0.397B 0.00
Organogenesis Holdings (ORGO) United States $0.386B 0.00
MEI Pharma (MEIP) United States $0.363B 0.00
Calithera Biosciences (CALA) United States $0.360B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.324B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.299B 0.00
Concert Pharmaceuticals (CNCE) United States $0.292B 0.00
Lannett Co Inc (LCI) United States $0.287B 6.29
PROFOUND MEDICL (PROF) Canada $0.274B 0.00
OptiNose (OPTN) United States $0.254B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.250B 0.00
CASI Pharmaceuticals (CASI) United States $0.249B 0.00
Redhill Biopharma (RDHL) Israel $0.244B 0.00
Taiwan Liposome (TLC) Taiwan $0.227B 0.00
KalVista Pharmaceuticals (KALV) United States $0.225B 0.00
Jounce Therapeutics (JNCE) United States $0.222B 5.29
Rafael Holdings (RFL) United States $0.222B 0.00
Nature's Sunshine Products (NATR) United States $0.183B 24.05
IMV INC (IMV) Canada $0.179B 0.00
Nivalis Therapeutics (ALPN) United States $0.177B 0.00
Aquestive Therapeutics (AQST) United States $0.159B 0.00
Altimmune (ALT) United States $0.154B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.153B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.136B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.121B 0.00
Champions Oncology (CSBR) United States $0.113B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.106B 0.00
Recro Pharma (REPH) United States $0.105B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.104B 0.00
Xeris Pharmaceuticals (XERS) United States $0.104B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.102B 0.00
MediWound (MDWD) Israel $0.100B 0.00
Otonomy (OTIC) United States $0.098B 0.00
Onconova Therapeutics (ONTX) United States $0.098B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.095B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.092B 0.00
CTI BioPharma (CTIC) United States $0.088B 0.00
Sundial Growers (SNDL) Canada $0.087B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.086B 0.00
Hemispherx BioPharma (AIM) United States $0.082B 0.00
Biomerica (BMRA) United States $0.077B 0.00
SCYNEXIS (SCYX) United States $0.072B 0.00
Heat Biologics (HTBX) United States $0.072B 0.00
Aclaris Therapeutics (ACRS) United States $0.070B 0.00
Lipocine (LPCN) United States $0.069B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.066B 0.00
CV Sciences (CVSI) United States $0.059B 0.00
RENEURON GP (RNUGF) United Kingdom $0.057B 0.00
Addex Therapeutics (ADXN) Switzerland $0.050B 0.00
Infinity Pharmaceuticals (INFI) United States $0.050B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.049B 29.45
PolarityTE (PTE) United States $0.049B 0.00
Natural Alternatives (NAII) United States $0.048B 0.00
Novan (NOVN) United States $0.043B 0.00
Forward Pharma (FWP) Denmark $0.042B 0.00
Mannatechorporated (MTEX) United States $0.042B 7.87
Entasis Therapeutics Holdings (ETTX) United States $0.041B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.041B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.040B 0.00
GTx (ONCT) United States $0.040B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.040B 84.64
IsoRay (ISR) United States $0.039B 0.00
Neos Therapeutics (NEOS) United States $0.035B 0.00
AgeX Therapeutics (AGE) United States $0.033B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.032B 0.00
ElectroCore (ECOR) United States $0.031B 0.00
Jaguar Animal Health (JAGX) United States $0.029B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.027B 0.00
India Globalization Capital (IGC) United States $0.022B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.022B 0.00
Iterum Therapeutics (ITRM) Ireland $0.021B 0.00
Flex Pharma (SLRX) United States $0.021B 0.00
Bio-Path Holdings (BPTH) United States $0.019B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.018B 0.00
Regulus Therapeutics (RGLS) United States $0.017B 0.00
ProPhase Labs (PRPH) United States $0.016B 0.00
China SXT Pharmaceuticals (SXTC) China $0.016B 0.00
Can-Fite Biopharma (CANF) Israel $0.015B 0.00
Shineco (TYHT) China $0.014B 0.00
Cyanotech (CYAN) United States $0.014B 32.71
Sonoma Pharmaceuticals (SNOA) United States $0.011B 0.00
RXi Pharmaceuticals (PHIO) United States $0.010B 0.00
HANCOCK JAFFE (HJLI) United States $0.010B 0.00
Vical (BBI) United States $0.010B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.010B 0.00
Midatech Pharma (MTP) United Kingdom $0.009B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00